genetic disorders Intermountain Primary Children's Hospital Launches HerediGene Children's Study The DNA mapping effort will collect 50,000 DNA samples from children as young as newborns, as well as any parents and siblings who wish to participate. Bionano Genomics Stock Soars on User Presentations, Public Stock Offering, Renewed Nasdaq Compliance Buoyed by a string of positive news, the San Diego firm's stock was up 22 percent in Friday afternoon trading and 80 percent from last week. Children's Mercy Hospital Raises $16M for Pediatric Genomic Repository Initiative The effort, which will be the flagship project of the Children's Mercy Research Institute, aims to collect genomic data from 30,000 children and their families. Pacific Biosciences, Asuragen Collaborate on Clinical Assays Asuragen will develop assays for PacBio's long-read next-generation sequencing systems, with an initial focus on developing a carrier screening assay. Yourgene Health Gets CE Mark for Iona NIPT Test The test has been developed to run on Illumina's NextSeq 550Dx next-generation sequencing platform and will be prepared for commercial launch in Europe. Jun 2, 2020 Ravgen Sues Natera Over Cell-Free DNA Genetic Testing Patents May 5, 2020 Invitae Q1 Revenues Grow 58 Percent Apr 27, 2020 Illumina Loses Appeal for Injunction Against Ariosa Diagnostics, but Court Upholds $27M Judgment Apr 13, 2020 Natera Expects 35 Percent Rise in Q1 Revenues, Proposes $250M Senior Notes Offering Mar 17, 2020 US Appeals Court Overturns Roche Win in Illumina NIPT Suit Jan 9, 2020 Mayo Clinic, Helix Partner for 100K-Patient Clinical Genomics Study Premium Dec 11, 2019 Study Shows Feasibility of Circulating Trophoblast-Based Noninvasive Prenatal Testing Premium Nov 8, 2019 Some Call for Expanded Payor Coverage of NIPS but Reluctance Remains Premium Sep 16, 2019 Fulgent Genetics Taps PWNHealth to Oversee New Tests Marketed to Consumers Sep 13, 2019 Natera Finds High Performance for Noninvasive Prenatal Test in All Age Groups Premium Jul 10, 2019 NIPD Genetics Enters Cancer Dx Market, Expands Prenatal Testing Premium Apr 24, 2019 Rady Team Automates Rapid Pediatric Sequence Interpretation for Rare Disease Dx Apr 23, 2019 Illumina, Chinese Children's Hospital to Launch Newborn Sequencing Study Jan 28, 2019 Horizon Discovery, Rutgers Collaborate to Commercialize CRISPR Base Editing Technology Dec 11, 2018 Centogene Inks Drug Discovery, Development Deal With Chiesi Oct 9, 2018 Fulgent Genetics, StemCyte Partner on Genetic Testing Aug 16, 2018 Tufts Medical Center, Collaborators Win $8M NIH Grant to Study NGS in Newborns Jul 16, 2018 PARP Inhibitors May Benefit Patients With Rare Hereditary Cancer Syndromes Jun 8, 2018 With Edico Buy, Illumina to Focus on Rare Disease Diagnostic Sequencing Market Premium May 29, 2018 Centogene Partners With Aldeyra to Identify Rare Disease Patients Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.